Head of Quality, Compliance and Training, Global Patient Safety and Risk Management

  Apply  

Irfa******

  • United States 
  • Last Update: 10.07.2019 at 12:00

Job Type
Full Time
Start
ASAP
Duration
6 Month +
Place
300 3rd St, Cambridge, MA 02142
Country
United States

Category


Regulatory, Quality and Clinical

Description


Head of Quality, Compliance and Training

Overview

Alnylam is the industry leader in the translation of RNA interference (RNAi) into a new class of innovative medicines with the potential to address the unmet needs of patients with debilitating diseases. Founded in 2002, Alnylam was built upon a bold vision of turning scientific possibility into reality, and is now advancing a robust pipeline of investigational RNAi therapeutic medicines, including five programs in late-stage development. In 2018, Alnylam received approval for our first product, the first-ever RNAi therapeutic, by the FDA in the U.S. for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults and by the European Medicines Agency in the EU for the treatment of hATTR amyloidosis in adults with stage 1 or stage 2 polyneuropathy. Headquartered in Cambridge, Mass., Alnylam employs over 1,200 people in 18 countries and is rapidly growing globally, with additional offices in Norton, Mass., Maidenhead, U.K., Zug, Switzerland, Amsterdam, Netherlands, and Tokyo, Japan. Alnylam is proud to have been recognized as one of The Boston Globe

Get In Touch


downloadfilmterbaru.xyz bigoporn.club bok3p.site sablonpontianak.com